Segui
Gianluca Campo
Gianluca Campo
U.O. Cardiologia, Azienda Ospedaliera di Ferrara
Email verificata su unife.it
Titolo
Citata da
Citata da
Anno
Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy
O De Filippo, F D’Ascenzo, F Angelini, PP Bocchino, F Conrotto, ...
New England Journal of Medicine 383 (1), 88-89, 2020
11132020
Five-year outcomes with PCI guided by fractional flow reserve
P Xaplanteris, S Fournier, NHJ Pijls, WF Fearon, E Barbato, PAL Tonino, ...
New England Journal of Medicine 379 (3), 250-259, 2018
8132018
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial
M Valgimigli, G Campo, M Monti, P Vranckx, G Percoco, C Tumscitz, ...
Circulation 125 (16), 2015-2026, 2012
8102012
Short physical performance battery and all-cause mortality: systematic review and meta-analysis
R Pavasini, J Guralnik, JC Brown, M di Bari, M Cesari, F Landi, B Vaes, ...
BMC medicine 14, 1-9, 2016
7522016
Complete revascularization with multivessel PCI for myocardial infarction
SR Mehta, DA Wood, RF Storey, R Mehran, KR Bainey, H Nguyen, ...
New England Journal of Medicine 381 (15), 1411-1421, 2019
6852019
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised …
P Vranckx, M Valgimigli, L Eckardt, J Tijssen, T Lewalter, G Gargiulo, ...
The Lancet 394 (10206), 1335-1343, 2019
5962019
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year …
PW Serruys, B Chevalier, Y Sotomi, A Cequier, D Carrié, JJ Piek, ...
The Lancet 388 (10059), 2479-2491, 2016
5842016
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: relationship with gene polymorphisms and …
G Campo, G Parrinello, P Ferraresi, B Lunghi, M Tebaldi, M Miccoli, ...
Journal of the American College of Cardiology 57 (25), 2474-2483, 2011
4112011
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial
M Valgimigli, G Percoco, P Malagutti, G Campo, F Ferrari, D Barbieri, ...
Jama 293 (17), 2109-2117, 2005
4112005
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the …
M Valgimigli, G Campo, G Percoco, L Bolognese, C Vassanelli, ...
Jama 299 (15), 1788-1799, 2008
3482008
Diagnostic performance of in‐procedure angiography‐derived quantitative flow reserve compared to pressure‐derived fractional flow reserve: the FAVOR II Europe‐Japan study
J Westra, BK Andersen, G Campo, H Matsuo, L Koltowski, A Eftekhari, ...
Journal of the American Heart Association 7 (14), e009603, 2018
3162018
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates
M Valgimigli, A Patialiakas, A Thury, E McFadden, S Colangelo, G Campo, ...
Journal of the American College of Cardiology 65 (8), 805-815, 2015
3002015
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double …
M Valgimigli, G Campo, N de Cesare, E Meliga, P Vranckx, A Furgieri, ...
Circulation 119 (25), 3215-3222, 2009
271*2009
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a …
M Valgimigli, E Frigoli, S Leonardi, P Vranckx, M Rothenbühler, M Tebaldi, ...
The Lancet 392 (10150), 835-848, 2018
2702018
Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury
G Morciano, C Giorgi, M Bonora, S Punzetti, R Pavasini, MR Wieckowski, ...
Journal of molecular and cellular cardiology 78, 142-153, 2015
2592015
Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a …
M Sabaté, S Brugaletta, A Cequier, A Iñiguez, A Serra, ...
The Lancet 387 (10016), 357-366, 2016
2392016
Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary …
S Garg, G Sarno, PW Serruys, AE Rodriguez, L Bolognese, M Anselmi, ...
JACC: Cardiovascular Interventions 4 (1), 66-75, 2011
2152011
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C‐ring conformation
M Bonora, C Morganti, G Morciano, G Pedriali, ...
EMBO reports 18 (7), 1077-1089, 2017
1972017
Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction …
M Valgimigli, M Tebaldi, G Campo, S Gambetti, L Bristot, M Monti, ...
JACC: Cardiovascular Interventions 5 (3), 268-277, 2012
1962012
Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials
M Valgimigli, G Biondi-Zoccai, M Tebaldi, AWJ van't Hof, G Campo, ...
European Heart Journal 31 (1), 35-49, 2010
1862010
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20